C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2002
12/11/2002	CN1095677C 化合物 Compound
12/10/2002	US6492508 Nucleic acids encoding extracellular matrix proteins
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492496 Antibodies to the receptor protein designated 2F1
12/10/2002	US6492495 PTP-S31: a novel protein tyrosine phosphatase
12/10/2002	US6492493 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/10/2002	US6492492 Wild type streptavidin carboxyl terminal amino acid and the amino terminal amino acid of the wild type streptavidin have been joined directly or via a linker, and wherein new carboxyl and amino termini have been created by cleavage
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
12/10/2002	US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that
12/10/2002	US6492152 Nucleic acids encoding the core 1 .beta.3-galactosyl transferases are described. the enzymes and the nucleic acids encoding said enzymes have been identified in human, rat, mouse d. melanogaster and c. elegans. the polypeptides exhibit
12/10/2002	US6492148 A method for the preparation of an infectious ibdv mutant which will replicate in cef cell culture, comprising: separately preparing a dna construct comprising cdna of genome segments a and b of an ibdv which is not capable of
12/10/2002	US6492140 Polynucleotides encoding cytokine designated LERK-5
12/10/2002	US6492137 Response element compositions and assays employing same
12/10/2002	US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection
12/10/2002	US6491926 35 kD tumor associated protein antigen: uses and methods of detection
12/10/2002	US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	US6491915 Anti-CCR2 antibodies and methods of use therefor
12/10/2002	CA2212150C Monoclonal antibodies for human osteogenic cell surface antigens
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA2114015C Recombinant antibodies for human therapy
12/10/2002	CA2094533C Hydrocolloid wound gel
12/10/2002	CA2085127C Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
12/10/2002	CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002	CA2077764C Antibody to pacap and use thereof
12/10/2002	CA2047290C Recombinant marek's disease virus
12/10/2002	CA1341407C Minactivin
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097122A1 Secretion of proteins by encapsulated cells
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	WO2002097088A1 Testicular carnitine transporter and its gene
12/05/2002	WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
12/05/2002	WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097051A2 Protein arrays and methods and systems for producing the same
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096948A2 Engineered tetravalent antibodies and methods of use
12/05/2002	WO2002096946A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy30
12/05/2002	WO2002096942A2 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096350A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	WO2002068470A3 Interferon-alpha induced gene
12/05/2002	WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities
12/05/2002	WO2002062957A9 Ter sites and ter binding proteins
12/05/2002	WO2002059150A3 Materials and methods relating to protein aggregation in neurodegenerative disease
12/05/2002	WO2002053758A3 Method for producing heterologous proteins in a homothallic fungus of the sordariaceae family
12/05/2002	WO2002028902A3 Nectin polypeptides, polynucleotides, methods of making and use thereof
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	WO2002020766A3 G-csf analog compositions and methods
12/05/2002	WO2002000715A3 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
12/05/2002	WO2001088085A3 Novel bee venom polypeptides and methods of use thereof
12/05/2002	WO2001079448A3 Trp8, a transient receptor potential channel expressed in taste receptor cells
12/05/2002	WO2001060397A9 Uses of agonists and antagonists to modulate activity of tnf-related molecules
12/05/2002	WO2001021796A9 Gl50 molecules and uses therefor
12/05/2002	US20020183510 Methods and apparatus to synthesize primordial life from inanimate materials
12/05/2002	US20020183509 Generation of preferential nucleotide sequences library; obtain nucleotide sequences, denature, hybridize to primers, remove and recover nucleotide sequences expressing signal
12/05/2002	US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183500 Nucleotide sequence coding polypeptide for use in the treatment, diagnosis, classification and imaging of lung cancer
12/05/2002	US20020183496 Human thymosin beta15 gene, protein and uses thereof
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183485 Nucleotide sequences coding receptor protein for use in the treatment of hypertriglyceridaemia, inflammation, cachexia, infections and tumors
12/05/2002	US20020183269 Novel compounds
12/05/2002	US20020183250 For use in therapy of sleep disorders
12/05/2002	US20020182728 Method for transdifferentiation of non pancreatic stem cells to the pancreatic differentiation pathway
12/05/2002	US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/05/2002	US20020182706 Purification of viral envelope proteins; obtain cell, transfect with genetically engineered virus, lyse cell, recover envelope proteins
12/05/2002	US20020182703 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment
12/05/2002	US20020182685 In vivo generation of antibodies against antigens secreted in a host by transfected MEL cells
12/05/2002	US20020182684 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders
12/05/2002	US20020182683 Vascular endothelial growth factor 2
12/05/2002	US20020182682 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides
12/05/2002	US20020182676 Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexia
12/05/2002	US20020182673 Nucleotide sequences coding polypeptide for use in the treatment of degenerative, bone and inflammatory disorders
12/05/2002	US20020182671 Polypeptide for use in the treatment, diagnosis, and prevention of cell proliferative, autoimmune/inflammatory, neurological and gatrointestinal disorders
12/05/2002	US20020182667 Methods of modulating T lymphocyte costimulation
12/05/2002	US20020182649 Detection of preferential protein in sample; obtain target protein, generate protein cleavage products, detect products, compare to control
12/05/2002	US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182221 Recombinant papillomavirus vaccine and method for production and treatment
12/05/2002	US20020182210 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/05/2002	US20020182208 Glycosylated antibody
12/05/2002	US20020182207 Contacting said target molecule with a catalyst capable of chemically modifying said target molecule; catalyzing the attachment of the label to the target substance
12/05/2002	CA2665748A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
12/05/2002	CA2449127A1 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
12/05/2002	CA2449000A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448171A1 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 1125